MTIP leads Series B round for Oviva
Oviva, a digital provider of Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding.
Oviva, a digital provider of Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination